Acute lymphoblastic leukemia
CH Pui, WE Evans - New England Journal of Medicine, 1998 - Mass Medical Soc
Acute lymphoblastic leukemia (ALL) is diagnosed in 3000 to 4000 persons in the United
States each year; two thirds of them are children. 1, 2 The current rate of cure of nearly 80 …
States each year; two thirds of them are children. 1, 2 The current rate of cure of nearly 80 …
Antigen expression patterns reflecting genotype of acute leukemias
O Hrušák, A Porwit-MacDonald - Leukemia, 2002 - nature.com
Multi-parameter flow cytometry, molecular genetics, and cytogenetic studies have all
contributed to new classification of leukemia. In this review we discuss immunophenotypic …
contributed to new classification of leukemia. In this review we discuss immunophenotypic …
Children's Oncology Group AALL0434: a phase III randomized clinical trial testing nelarabine in newly diagnosed T-cell acute lymphoblastic leukemia
KP Dunsmore, SS Winter, M Devidas… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Nelarabine is effective in inducing remission in patients with relapsed and
refractory T-cell acute lymphoblastic leukemia (T-ALL) but has not been fully evaluated in …
refractory T-cell acute lymphoblastic leukemia (T-ALL) but has not been fully evaluated in …
Improved survival for children and young adults with T-lineage acute lymphoblastic leukemia: results from the Children's Oncology Group AALL0434 methotrexate …
SS Winter, KP Dunsmore, M Devidas… - Journal of Clinical …, 2018 - ascopubs.org
Purpose Early intensification with methotrexate (MTX) is a key component of acute
lymphoblastic leukemia (ALL) therapy. Two different approaches to MTX intensification exist …
lymphoblastic leukemia (ALL) therapy. Two different approaches to MTX intensification exist …
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
M Schrappe, MG Valsecchi, CR Bartram… - Blood, The Journal …, 2011 - ashpublications.org
The prognostic value of MRD in large series of childhood T-ALL has not yet been
established. Trial AIEOP-BFM-ALL 2000 introduced standardized quantitative assessment of …
established. Trial AIEOP-BFM-ALL 2000 introduced standardized quantitative assessment of …
Racial and ethnic differences in survival of children with acute lymphoblastic leukemia
S Bhatia, HN Sather, NA Heerema… - Blood, The Journal …, 2002 - ashpublications.org
Black children with acute lymphoblastic leukemia (ALL) have poor outcomes, but limited
information is available for children from other racial and ethnic backgrounds, such as …
information is available for children from other racial and ethnic backgrounds, such as …
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study
The early thymic precursor (ETP) immunophenotype was previously reported to confer poor
outcome in T-cell acute lymphoblastic leukemia (T-ALL). Between 2009 and 2014, 1256 …
outcome in T-cell acute lymphoblastic leukemia (T-ALL). Between 2009 and 2014, 1256 …
Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's …
Abstract The Pediatric Oncology Group (POG) phase 3 trial 9404 was designed to determine
the effectiveness of high-dose methotrexate (HDM) when added to multi-agent …
the effectiveness of high-dose methotrexate (HDM) when added to multi-agent …
[HTML][HTML] Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications
AG Jegalian, NP Buxbaum, F Facchetti, M Raffeld… - …, 2010 - ncbi.nlm.nih.gov
Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical
implications - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
implications - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies
NLM Liem, RA Papa, CG Milross, MA Schmid… - Blood, 2004 - ashpublications.org
Continuous xenografts from 10 children with acute lymphoblastic leukemia (ALL) were
established in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice …
established in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice …